Albireo Pharma Inc (NASDAQ:ALBO)

32.95
Delayed Data
As of May 22
 +0.15 / +0.46%
Today’s Change
15.31
Today|||52-Week Range
39.87
+28.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 1
2018
AssetsCash20.1M62.6M57.1M192.9M
 
 
 
 
 
Short Term Investment Cash-9.8M42.5M-5.5M139.7M
 
 
 
 
 
Cash & Short Term Investments20.1M62.6M57.1M192.9M
 
 
 
 
 
 
ReceivablesReceivables641.0K663.0K741.0K1.4M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets553.0K471.0K326.0K661.0K
 
 
 
 
 
Current Assets21.3M63.7M58.1M195.0M
 
 
 
 
 
 
Total AssetsIntangible Assets18.3M18.3M18.3M17.3M
 
 
 
 
 
Other Assets18.9M18.8M18.8M17.7M
 
 
 
 
 
Total Assets40.3M82.7M77.1M212.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.3M1.3M1.6M2.2M
 
 
 
 
 
Short Term Debt2.5M1.9M1.5M0.00
 
 
 
 
Accrued Expenses3.9M3.8M4.6M4.5M
 
 
 
 
 
Other Current Liabilities5.3M4.1M4.9M4.9M
 
 
 
 
 
Other Liabilities9.1M7.4M7.9M7.2M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities21.0K43.0K43.0K45.6M
 
 
 
 
 
Total Liabilities9.1M7.4M8.0M52.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.00--0.00--
Common Equity31.2M75.3M69.1M160.2M
 
 
 
 
 
Total Shareholder Equity31.2M75.3M69.1M160.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding6.3M8.9M8.9M11.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.